Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1Caroline Imbert, Céline Colacios, Odile Burlet‐Schiltz et al.|Nature Communications|2020Cited by 121
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapyCaroline Lefèbvre, Julien Mazières, E. Martin et al.|Respiratory Medicine and Research|2020Cited by 8
P1.01-120 Immune Checkpoint Inhibitors Versus Second Line Chemotherapy for Patients with Lung Cancer Refractory to First Line ChemotherapyCaroline Lefèbvre, Julien Mazières, E. Martin et al.|Journal of Thoracic Oncology|2019Cited by 1
IMMUNOPROG : efficacité des inhibiteurs de point de contrôle immunitaire (ICI) chez des patients porteurs d’un carcinome bronchique non à petites cellules réfractaire à une chimiothérapie de première ligneCaroline Lefèbvre, Julien Mazières, Rémi Veillon et al.|Revue des Maladies Respiratoires|2018Cited by 0